Association between BC and blood markers were not observed in main effects models or when stratified by obesity status; BC was positively associated with markers of inflammation in men with CHD (particularly vascular endothelial growth factor) and in men with diabetes (particularly interleukin-1β and tumor necrosis factor-α). Here, VEGFA is linked to obesity disorder.